• Urolithin A in Precision Mitochondrial Research: Mechanisms

  2026-06-01

  Explore how Urolithin A, a gut microbiota-derived metabolite, is advancing mitochondrial biogenesis research and skeletal muscle gene modulation. This article uniquely connects mechanistic insights with actionable protocols and the latest reference breakthroughs.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-06-01

  Song et al. uncover how murine norovirus leverages NINJ1, a plasma membrane rupture effector, to selectively export the viral NS1 protein via a regulated, unconventional secretory pathway. This work provides new mechanistic insight into host-pathogen interactions, apoptosis, and the specificity of large protein release during infection.

• circUSP10 as a Diagnostic Biomarker in Early-Stage NSCLC

  2026-05-31

  Bai et al. identify circUSP10, a circular RNA, as a promising diagnostic biomarker for early-stage non-small-cell lung cancer (NSCLC), demonstrating its stability and elevated expression in patient blood samples. This discovery offers a potential tool for improving early detection and may inform future RNA-based therapeutic strategies.

• Advanced Protocols for Plant Protein Secretion and pH Sensin

  2026-05-30

  The second edition of 'Plant Protein Secretion: Methods and Protocols' delivers rigorously validated, stepwise procedures for dissecting plant-specific protein secretion pathways. By integrating detailed workflows, troubleshooting guidance, and support for live-cell readouts such as intracellular pH measurement, this reference advances reproducibility and mechanistic insight in plant cell biology.

• D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Workf

  2026-05-29

  D-Luciferin sodium salt from APExBIO is the benchmark substrate for sensitive, quantitative bioluminescence imaging in live-cell and in vivo assays. This article bridges recent advances in CAR macrophage immunotherapy with practical assay design, troubleshooting, and data-driven optimization for cell viability and metabolism research.

• Taltirelin Acetate: Applied Protocols and Breakthroughs in N

  2026-05-29

  Taltirelin acetate stands out as a long-acting TRH analog, advancing preclinical research in neuroprotection, itch, and sleep apnea. This guide translates key findings into optimized workflows, troubleshooting strategies, and actionable protocol enhancements for robust experimental outcomes.

• HyperScript™ Reverse Transcriptase: Advancing cDNA Synthesis

  2026-05-28

  HyperScript™ Reverse Transcriptase from APExBIO sets a new benchmark for cDNA synthesis, excelling with challenging RNA templates and low-copy targets. Its engineered thermal stability and high affinity drive robust performance in advanced qPCR and transcriptomics applications.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit in Nucleic Ac

  2026-05-28

  Discover how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit transforms RNA probe synthesis for advanced fluorescence imaging and mechanistic studies. This article reveals unique insights into probe design, regulatory RNA detection, and practical assay strategies, distinguishing itself from standard protocol guides.

• Helper-Polymer FNPs Enable Stable, Lung-Targeted mRNA Delive

  2026-05-27

  The reference study introduces five-element nanoparticles (FNPs) leveraging poly(β-amino esters) as helper polymers to achieve lung-specific mRNA delivery with remarkable post-lyophilization stability. These findings provide a potential solution to longstanding barriers in mRNA therapeutics for pulmonary diseases, notably overcoming the instability of traditional lipid nanoparticles.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-27

  This article examines a recent study demonstrating how tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. The findings offer mechanistic insights into mRNA-based restoration of tumor suppressor pathways and highlight practical approaches for enhancing therapeutic responses.

• Redefining Apoptosis Detection: Strategy and Mechanism for T

  2026-05-26

  This thought-leadership article explores the evolving landscape of apoptosis detection, bridging mechanistic insight into DNA fragmentation with practical guidance for translational researchers. Drawing on recent advances in cell death pathway analysis, we contextualize the One-step TUNEL Cy3 Apoptosis Detection Kit within contemporary experimental workflows, scrutinize its competitive differentiation, and articulate the kit’s strategic role in addressing research and clinical bottlenecks—escalating the discussion beyond classic product page coverage.

• Alda 1 as an ALDH2 Activator: Redefining Cardiac Regeneratio

  2026-05-26

  Explore Alda 1, a potent ALDH2 activator, and its pivotal role in cardiac regeneration and ischemia research. This in-depth article uniquely analyzes how Alda 1 advances cardiomyocyte proliferation studies, offering insights beyond standard cardioprotection and dermatitis models.

• β-Amanitin: Empowering Translational Insights in RNA Polymer

  2026-05-25

  β-Amanitin, a selective RNA polymerase II inhibitor, is transforming transcriptional regulation research. This thought-leadership article integrates mechanistic insight, practical protocol guidance, and strategic analysis of detection trends—highlighting APExBIO’s high-purity β-Amanitin as a tool for advancing translational and toxicological investigations.

• Astrocyte Heterogeneity Mapped Across Brain Regions and Time

  2026-05-25

  Schroeder et al. present a comprehensive transcriptomic atlas of astrocytes, revealing how regional heterogeneity evolves during development in mouse and marmoset brains. Their work combines single-nucleus RNA sequencing and advanced imaging to uncover region- and species-specific molecular and morphological distinctions, offering a high-resolution resource for studying astrocyte specialization.

• Atorvastatin as an HMG-CoA Reductase Inhibitor: Advanced Wor

  2026-05-24

  Atorvastatin from APExBIO empowers researchers to go beyond cholesterol metabolism, enabling sophisticated workflows in both vascular and oncology research. This article distills experimental protocols, troubleshooting strategies, and actionable insights for maximizing the translational impact of this versatile HMG-CoA reductase inhibitor.

7710 records 12/514 page Previous Next First page 上5页 1112131415 下5页 Last page